We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Urine Analyzer for Point-of-Care Testing

By HospiMedica staff writers
Posted on 27 Jun 2006
A urine chemistry analyzer has been launched that provides low-cost, automated urinalysis for point-of-care testing.

Urine analysis provides important markers to detect early stages of many disease states such as diabetes, kidney disease, and urinary tract infections. More...
Clinitek Status is the latest addition to the range of Bayer Diagnostics' (Terrytown, NY, USA) urine analysis products. Designed to integrate with both point-of-care and laboratory workflow, Clinitek Status improves urine testing reliability while minimizing the "hands-on” testing time typically required when visually reading urine reagent test strips.

In conjunction with the launch of the analyzer, Bayer Diagnostics has also released Clinitest Status hCG, an automated, rapid, and highly-sensitive test for the determination of pregnancy.

The Clinitek Status analyzer offers medical professionals, through an easy-to-use touch screen display, the ability to record patient information and operator identification. It also offers a 200-test result memory with result printouts. The Clinitek Status is compatible with a wide range of Bayer HealthCare's Multistix urine test strips.

"When the Clinitek Status first came out everybody wanted one,” said Jan Still, point-of-care testing manager for West Hertfordshire Hospitals Trust (UK). "The big attraction for staff is the ability to perform both types of test on a single ‘walk away' instrument which is not only designed to save time but also prints our results which are unequivocal.”



Related Links:
Bayer Diagnostics

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Multi-Chamber Washer-Disinfector
WD 390
Hypodermic Syringe
SurTract™ Safety Syringe
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: New findings show that chemotherapy plus immunotherapy before surgery produced greater tumor destruction than immunotherapy alone in head and neck cancer patients (Image Credit: Adobe Stock)

Combination Therapy Before Surgery Drives Stronger Tumor Reduction in Head and Neck Cancer

Patients with head and neck cancer who are scheduled for surgery often face a waiting period with limited treatment, creating an opportunity to reduce viable tumor burden before the operation.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.